Copyright
©The Author(s) 2018.
World J Cardiol. Jun 26, 2018; 10(6): 41-48
Published online Jun 26, 2018. doi: 10.4330/wjc.v10.i6.41
Published online Jun 26, 2018. doi: 10.4330/wjc.v10.i6.41
Figure 1 Forest plot and pooled analysis for recurrent ischemic stroke (n = 3440) in cryptogenic stroke patients (patent foramen ovale closure vs medical therapy alone).
RR: Relative risk.
- Citation: Anantha-Narayanan M, Anugula D, Das G. Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials. World J Cardiol 2018; 10(6): 41-48
- URL: https://www.wjgnet.com/1949-8462/full/v10/i6/41.htm
- DOI: https://dx.doi.org/10.4330/wjc.v10.i6.41